Oncology social workers play an important role on the multidisciplinary care team and in the delivery of patient-centered care. Whether assisting patients through treatment challenges, suggesting resources to minimize financial toxicity, or helping them cope with psychosocial distress, ACCC understands the critical need for oncology social workers.
ACCC-member social work professionals are best positioned to share key insights for developing resources that support efficient and effective delivery of state-of-the-art psychosocial and supportive care. Whether you come from a small community practice, large academic medical program, or anywhere in between, a variety of opportunities await your knowledge and experience. Click "Apply Now" to add your name to the Volunteer Registry and tell us more about you, so we can contact you for opportunities of interest.

From Ghana to Orlando, experts across the multidisciplinary care team share how they are expanding access to clinical trials and supportive care services and improving quality of life for their patients as a result in this Oncology Issues. Read on for a preview of this issue’s articles and dive deeper to learn from colleagues across the country and the globe.

On day 1 of the NCCN 2026 Annual Conference, attendees heard from experts on the unique issues young adults with cancer face during and post-treatment, advances in treating gastrointestinal cancers, evolving therapies in skin cancers, and novel approaches to treating blood cancers.

ACCCBuzz interviewed leadership from the National Association of Veterans’ Research and Education Foundations to better understand the current clinical and operational barriers Veterans face in accessing clinical trials and the progress being made to address them.

In an effort to improve outcomes and deliver the highest quality of care to patients with pancreatic cancer, Duke Cancer Institute launched a multidisciplinary Pancreatic Cancer Center that prioritizes thorough surveillance of high-risk patients, stays at the forefront of clinical trials, and considers the role of comorbidities.
